9 research outputs found
Temporal variation in growth of yellowfin tuna (Thunnus albacares) larvae in the Panama Bight, 1990
Tuna larvae (at flexion, postflexion, and transformation
stages) were collected by dip net and light traps at night in the northwestern Panama Bight during the season of
reduced upwelling (June−September) of 1990, 1991, 1992, and 1997. The larvae were identified as yellowfin tuna (Thunnus albacares) by mtDNA analysis. Ichthyoplankton data from
bongo and Tucker trawl tows were used to examine the potential prey abundance in relation to the mean
size-at-age and growth rates of the yellowfin tuna larvae and their otoliths. The most rapid growth rates occurred during June 1990 when plankton volumes were at their
highest levels. The lowest plankton volumes coincided with the lowest growth rates and mean sizes-at-age during the August−September 1991 period. High densities of larval fish
were prevalent in the ichthyoplankton tows during the 1991 period; therefore intra- and interspecific competition
for limited food resources may have been the cause of slower growth (density-dependent growth) in yellowfin
tuna larvae The highest mean seasurface temperature and the lowest mean wind stress occurred during an El Niño-Southern Oscillation (ENSO) event during the 1997 period. There
appeared to be no clear association between these environmental factors and larval growth rates, but the higher temperatures may have caused an increase in the short-term growth of otoliths in rela
Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells
<p>Abstract</p> <p>Background</p> <p>Pregnane X receptor (PXR) is a key transcription factor that regulates drug metabolizing enzymes such as cytochrome P450 (CYP) 3A4, and plays important roles in intestinal first-pass metabolism. Although there is a large inter-individual heterogeneity with intestinal CYP3A4 expression and activity, the mechanism driving these differences is not sufficiently explained by genetic variability of PXR or CYP3A4. We examined whether epigenetic mechanisms are involved in the regulation of PXR/CYP3A4 pathways in colon cancer cells.</p> <p>Methods</p> <p>mRNA levels of PXR, CYP3A4 and vitamin D receptor (VDR) were evaluated by quantitative real-time PCR on 6 colon cancer cell lines (Caco-2, HT29, HCT116, SW48, LS180, and LoVo). DNA methylation status was also examined by bisulfite sequencing of the 6 cell lines and 18 colorectal cancer tissue samples. DNA methylation was reversed by the treatment of these cell lines with 5-aza-2'-deoxycytidine (5-aza-dC).</p> <p>Results</p> <p>The 6 colon cancer cell lines were classified into two groups (high or low expression cells) based on the basal level of PXR/CYP3A4 mRNA. DNA methylation of the CpG-rich sequence of the <it>PXR </it>promoter was more densely detected in the low expression cells (Caco-2, HT29, HCT116, and SW48) than in the high expression cells (LS180 and LoVo). This methylation was reversed by treatment with 5-aza-dC, in association with re-expression of PXR and CYP3A4 mRNA, but not VDR mRNA. Therefore, PXR transcription was silenced by promoter methylation in the low expression cells, which most likely led to downregulation of CYP3A4 transactivation. Moreover, a lower level of <it>PXR </it>promoter methylation was observed in colorectal cancer tissues compared with adjacent normal mucosa, suggesting upregulation of the PXR/CYP3A4 mRNAs during carcinogenesis.</p> <p>Conclusions</p> <p><it>PXR </it>promoter methylation is involved in the regulation of intestinal PXR and CYP3A4 mRNA expression and might be associated with the inter-individual variability of the drug responses of colon cancer cells.</p